A biomarker panel for risk of early respiratory failure following hematopoietic cell transplantation

Plasma biomarkers associated with respiratory failure (RF) following hematopoietic cell transplantation (HCT) have not been identified. Therefore, we aimed to validate early (7 and 14 days post-HCT) risk biomarkers for RF. Using tandem mass spectrometry, we compared plasma obtained at day 14 post-HC...

Descripción completa

Detalles Bibliográficos
Autores principales: Rowan, Courtney M., Smith, Lincoln, Sharron, Matthew P., Loftis, Laura, Kudchadkar, Sapna, Duncan, Christine N., Pike, Francis, Carpenter, Paul A., Jacobsohn, David, Bollard, Catherine M., Cruz, Conrad Russell Y., Malatpure, Abhijeet, Farag, Sherif, Renbarger, Jamie, Little, Morgan R., Gafken, Phillip R., Krance, Robert A., Cooke, Kenneth R., Paczesny, Sophie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2022
Materias:
Hematopoiesis and Stem Cells
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8941462/
https://www.ncbi.nlm.nih.gov/pubmed/35139145
http://dx.doi.org/10.1182/bloodadvances.2021005770

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8941462/
https://www.ncbi.nlm.nih.gov/pubmed/35139145
http://dx.doi.org/10.1182/bloodadvances.2021005770

Ejemplares similares